severity of COPD
Vitamin D deficiency is associated with the severity of COPD: a systematic review and meta-analysis
10
ECG and Echocardiographic Findings in COPD and the Correlation of Right Ventricular Dysfunction with the Severity of COPD
113
Colds as predictors of the onset and severity of COPD exacerbations
10
Multidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD
11
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims
9
Electrocardiographic characteristics of patients with chronic obstructive pulmonary disease and its correlation with disease severity
5
Utility estimation of hypothetical chronic obstructive pulmonary disease health states by the general population and health professionals
7
Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease
15
Association between Severity of Chronic Obstructive Pulmonary Disease and Lung Function Tests
6
Depression predicts emergency care use in people with Chronic Obstructive Pulmonary Disease: A large cohort study in primary care
20
Serum levels of vascular endothelial growth factor in chronic Obstructive pulmonary disease
6
The Relationship between COPD Assessment Test (CAT) Scores and Severity of Airflow Obstruction in Stable COPD Patients
5
Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity
10
Clinical characteristics and quality of life in women with COPD: an observational study
6
Chronic obstructive pulmonary disease phenotype desaturator with hypoxic vascular remodelling and pulmonary hypertension obtained by cluster analysis
7
Quality of life and its association with direct medical costs for COPD in urban China
6
COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma–COPD overlap syndrome
9
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group, multicentre study
11
Impact of a clinical pharmacist intervention on medicine costs in patients with chronic obstructive pulmonary disease in India
12
Neutrophil-lymphocyte ratio as a marker of disease severity and exacerbation in COPD
118